Home » Topics » Regulatory

Regulatory
RSS

FDA approves product for hemophilia

Feb. 13, 1997

MGI Pharma seeks FDA approval of new indication for Salagen Tablets

Feb. 12, 1997

Novartis launches once-daily hypertension Rx

Feb. 12, 1997

NexMed licenses alprostadil cream

Feb. 12, 1997

Tretinoin gel cleared for marketing by FDA

Feb. 11, 1997

Cypress awarded grant for research related to its PROSORBA Column

Feb. 7, 1997

Alza signs licensing agreements for transdermal testesterone products

Feb. 7, 1997

First Corlopam Renal Program study completed

Feb. 6, 1997

New use of ciclosporin recommended for approval

Feb. 5, 1997

New use reported for a known veterinary anticoccidial agent

Jan. 31, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
FDA greenlights Medtronic Onyx subdural hematoma treatment
BioWorld MedTech
Sometimes the darkest products (names) bring a bright spot of news to their developers, as the U.S. FDA clearance for Galway, Ireland-based Medtronic plc's Onyx...